# ADVB (Advanced Biomed Inc.) - SEC EDGAR Financial Statements

> Advanced Biomed Inc. reported $128K in revenue and net income of $6.07M for the fiscal year ended June 30, 2026, with a -5337.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/ADVB
- Markdown: https://convexityos.com/fundamentals/ADVB.md
- SEC CIK: 0001941029
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001941029&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | $128K | Jun 30, 2026 |
| Operating Income | FY 2026 | -$6.81M | -5337.5% margin |
| Net Income | FY 2026 | $6.07M | 4759.5% net margin |
| Diluted EPS | FY 2026 | $3.68 | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: $33K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| **Revenue** | $128K | -- | -- |
| Research & Development | -- | $910K | $880K |
| Total Operating Expenses | $6.36M | $1.09M | $2.54M |
| **Operating Income** | -$6.23M | -$1.09M | -$2.54M |
| **EBITDA** | -- | -$743K | -$2.14M |
| Interest Income | -- | $25K | $53K |
| Income Before Tax | -$6.26M | -$1.09M | -$2.78M |
| Income Tax Expense | -$1.2K | -- | -- |
| **Net Income** | $6.68M | -$3.26M | -$2.78M |
| Basic EPS | $5.33 | -$3.18 | -$2.80 |
| **Diluted EPS** | $5.33 | -$3.18 | -$2.80 |
| Basic Shares Outstanding | 1.3M | 1.0M | 1.0M |
| Diluted Shares Outstanding | 1.3M | 1.0M | 1.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | -- | -- | $243K | $186K | $236K | $310K | $220K | $212K |
| Total Operating Expenses | $974K | $5.05M | $520K | $397K | $147K | $11K | $568K | $280K |
| **Operating Income** | -$974K | -$4.92M | -$520K | -$397K | -$147K | $227K | -$568K | -$280K |
| **EBITDA** | -- | -- | -$511K | -$409K | -$99K | $502K | -$545K | -$337K |
| Interest Income | -- | -- | -- | $9.2K | $448 | $9.5K | $26 | $15K |
| Income Before Tax | -$989K | -$12.52M | -$489K | $7.00M | -$147K | $676K | -$1.20M | -$579K |
| **Net Income** | -$989K | $695K | -$489K | $6.86M | -$387K | -$702K | -$1.38M | -$908K |
| Basic EPS | -$0.60 | -- | -$0.38 | $6.20 | -$0.36 | -- | -$1.35 | -$1.00 |
| **Diluted EPS** | -$0.60 | -- | -$0.38 | $6.20 | -$0.36 | -- | -$1.35 | -$1.00 |
| Basic Shares Outstanding | 1.7M | -- | 1.3M | 1.1M | 1.1M | -- | 1.0M | 1.0M |
| Diluted Shares Outstanding | 1.7M | -- | 1.3M | 1.1M | 1.1M | -- | 1.0M | 1.0M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | $2.87M | $2.61M |
| **Cash & Short-Term Investments** | -- | $2.87M | $2.61M |
| **Total Current Assets** | $13.75M | $22.38M | $3.05M |
| Property, Plant & Equipment, Net | -- | $125K | $525K |
| Intangible Assets | -- | -- | $119K |
| Other Non-Current Assets | -- | $2.6K | -- |
| **Total Non-Current Assets** | $1.2K | $480K | $1.41M |
| **Total Assets** | $13.75M | $22.86M | $4.46M |
| Accounts Payable | -- | $358K | $620K |
| **Total Current Liabilities** | $1.47M | $19.24M | $2.73M |
| **Total Non-Current Liabilities** | $0 | $146K | $65K |
| **Total Liabilities** | $1.47M | $19.38M | $2.80M |
| **Total Debt (incl. Leases)** | -- | $42K | $127K |
| Common Stock | $1.7K | $1.1K | $20K |
| Retained Earnings | -$12.56M | -$19.23M | -$15.97M |
| Accumulated Other Comp. Income | $969K | $1.34M | $1.12M |
| **Total Stockholders' Equity** | $12.28M | $3.48M | $1.66M |
| Total Equity | $12.28M | $3.48M | $1.66M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $2.60M | $2.66M | $2.87M | $5.18M | $2.66M |
| **Cash & Short-Term Investments** | -- | -- | -- | $2.60M | $2.66M | $2.87M | $5.18M | $2.66M |
| **Total Current Assets** | $12.87M | $13.75M | $10.53M | $10.73M | $5.84M | $22.38M | $7.73M | $3.14M |
| Property, Plant & Equipment, Net | -- | -- | $87K | $97K | $281K | $125K | $355K | $401K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $20K | $51K |
| Other Non-Current Assets | -- | -- | $2.2K | $956 | $75K | $2.6K | -- | -- |
| **Total Non-Current Assets** | $35K | $1.2K | $120K | $119K | $399K | $480K | $556K | $1.37M |
| **Total Assets** | $12.90M | $13.75M | $10.65M | $10.85M | $6.24M | $22.86M | $8.29M | $4.50M |
| Accounts Payable | -- | -- | $377K | $369K | $642K | $358K | $619K | $618K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $690K |
| **Total Current Liabilities** | $1.59M | $1.47M | $1.43M | $1.25M | $3.04M | $19.24M | $4.11M | $3.83M |
| **Total Non-Current Liabilities** | $24K | $0 | $11K | $115K | $194K | $146K | $44K | $56K |
| **Total Liabilities** | $1.61M | $1.47M | $1.44M | $1.37M | $3.24M | $19.38M | $4.16M | $3.89M |
| **Total Debt (incl. Leases)** | $33K | -- | $30K | $21K | $31K | $42K | $183K | $290K |
| Common Stock | $1.7K | $1.7K | $1.4K | $22K | $22K | $1.1K | $22K | $20K |
| Retained Earnings | -$13.55M | -$12.56M | -$13.25M | -$12.76M | -$19.62M | -$19.23M | -$18.53M | -$17.15M |
| Accumulated Other Comp. Income | $969K | $969K | $844K | $875K | $1.26M | $1.34M | $1.29M | $1.25M |
| **Total Stockholders' Equity** | $11.29M | $12.28M | $9.21M | $9.48M | $3.00M | $3.48M | $4.13M | $619K |
| Total Equity | $11.29M | $12.28M | $9.21M | $9.48M | $3.00M | $3.48M | $4.13M | $619K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| Net Income | $6.68M | -$3.26M | -$2.78M |
| Depreciation & Amortization | -- | $344K | $400K |
| Stock-Based Compensation | $1.73M | -- | -- |
| **Operating Cash Flow** | -$1.95M | -$5.83M | -$2.13M |
| Capital Expenditure | -- | -$32K | -$74K |
| **Free Cash Flow** | -- | -$5.86M | -$2.20M |
| **Investing Cash Flow** | -$2.51M | -$32K | -$74K |
| Common Stock Issued | $248K | $5.49M | -- |
| **Financing Cash Flow** | $1.97M | $5.93M | $1.87M |
| **Net Change in Cash** | -$2.52M | $296K | -$14K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$989K | $695K | -$489K | $6.86M | -$387K | -$702K | -$1.38M | -$908K |
| Depreciation & Amortization | -- | -- | $9.3K | -$13K | $48K | $276K | $23K | -$57K |
| **Operating Cash Flow** | -$171K | -$583K | -$240K | -$514K | -$610K | -$1.54M | -$3.41M | -$842K |
| Capital Expenditure | -- | -- | -$1.3K | -$13K | -$1.8K | -$20K | -$2.2K | $11K |
| **Free Cash Flow** | -- | -- | -$241K | -$526K | -$612K | -$1.56M | -$3.41M | -$831K |
| **Investing Cash Flow** | -- | -$2.49M | -$1.3K | -$13K | -$1.8K | -$20K | -$2.2K | $11K |
| **Financing Cash Flow** | -- | $937K | $268K | $315K | $447K | -$765K | $5.90M | $408K |
| **Net Change in Cash** | -$172K | -$2.22M | -$2.0K | -$46K | -$247K | -$2.28M | $2.53M | $10K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| **Operating Margin** | -4883.8% | -- | -- |
| **Net Profit Margin** | 5231.3% | -- | -- |
| Return on Equity (ROE) | 54.4% | -93.7% | -167.3% |
| Return on Assets (ROA) | 48.6% | -14.3% | -62.4% |
| Current Ratio | 9.33x | 1.16x | 1.12x |
| Quick Ratio | -- | 0.15x | 0.95x |
| Debt to Equity | -- | 0.01x | 0.08x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | 53.8% | 54.4% | 57.3% | 46.3% | -112.5% | -93.7% | -- | -- |
| Return on Assets (ROA) | 47.1% | 48.6% | 49.6% | 40.4% | -54.1% | -14.3% | -- | -- |
| Current Ratio | 8.09x | 9.33x | 7.38x | 8.56x | 1.92x | 1.16x | 1.88x | 0.82x |
| Quick Ratio | -- | -- | -- | 2.08x | 0.87x | 0.15x | 1.26x | 0.69x |
| Debt to Equity | 0.00x | -- | 0.00x | 0.00x | 0.01x | 0.01x | 0.04x | 0.47x |
| Operating Income Growth (YoY) | -- | -2272.1% | -- | -- | -- | -- | -- | -- |

## Related Companies

[KXIN (Kaixin Holdings)](https://convexityos.com/fundamentals/KXIN), [MVCO (Metavesco, Inc.)](https://convexityos.com/fundamentals/MVCO), [AUSI (Aura Systems, Inc.)](https://convexityos.com/fundamentals/AUSI), [SKYI (Sky Century Investment, Inc.)](https://convexityos.com/fundamentals/SKYI), [SER (Serina Therapeutics, Inc.)](https://convexityos.com/fundamentals/SER), [RDGL (Vivos Inc.)](https://convexityos.com/fundamentals/RDGL), [DLTI (Dlt Resolution, Inc.)](https://convexityos.com/fundamentals/DLTI), [CADL (Candel Therapeutics, Inc.)](https://convexityos.com/fundamentals/CADL)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
